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ABSTRAK 
 
 Polimorfisme atau mutasi pada gen spesifik P. falciparum dan P. vivax terlibat dalam resistensi 
terhadap obat antimalaria sulfadoksin-pirimetamin (SP). Di sisi lain gen msp-2 berperan penting dalam 
genotipe terkait resistensi obat. Studi ini dilakukan sebagai informasi dasar dalam menilai urgensi 
pengembangan vaksin malaria yang dapat dibuat dengan radiasi pengion. Asam deoksiribonukleat (DNA) 
darah dari pasien rawat jalan yang terinfeksi malaria di rumah sakit Dok II Jayapura pada periode 
Nopember 2014 diamplifikasi dengan menggunakan nested polymerase chain reaction (PCR) dan diikuti 
oleh analisis restriction fragment length polymorphism (RFLP) untuk menentukan polimorfisme resistensi 
SP. Di antara 15 sampel yang diuji untuk gen dhfr, 9 (60%) dan 8 (53%) sampel menunjukkan hasil positif 
untuk polimorfisme berturut-turut dengan primer JR78/79 dan F/108DH. Untuk gen dhps dengan 
menggunakan primer JR84/85 dan L/L, 7 sampel positif mutan. Frekuensi ini lebih rendah dibandingkan 
dengan hasil penelitian lain. Dari 15 sampel yang diperiksa, 3 memiliki alel 3D7 dan 4 memiliki alel FC27 
dari gen msp2. Tidak ada alel S1105 dan S1240 bermutasi dan 6 alel VDT mutan untuk P. vivax. Dapat 
disimpulkan bahwa resistensi parasit terhadap SP cukup tinggi, hal ini menunjukkan sangat pentingnya 
mengembangkan vaksin malaria. 
Kata kunci : resistensi, dhfr, dhps, mutasi, vaksin malaria 
 
ABSTRACT 
 
 Polymorphism or mutation in specific genes of P. falciparum and P. vivax is involved in the 
resistance to sulfadoxine-pyrimethamine (SP) antimalarial drug. On the other hand msp-2 gene plays an 
important role in drug resistance related genotyping. This study was undertaken as a basic information in 
assessing the urgent of development of malaria vaccine that can be created by ionizing radiation. Deoxy 
ribonucleic acid (DNA) of blood from malaria infected outpatients in Dok II Hospital of Jayapura for 
November 2014 period was amplified using nested polymerase chain reaction (PCR) and followed by 
restriction fragment length polymorphism (RFLP) analysis to determine the polymorphisms of SP 
resistance. Among 15 samples tested for dhfr gene, 9 (60%) and 8 (53%) samples showed positive result 
for polymorphisms in JR78/79 and F/108DH primers, respectively. For dhps gene by using JR84/85 and 
L/L primers 7 samples were positive mutant. These frequencies are lower compared to results of other 
research. of these 15 samples examined, 3 had 3D7 alleles and 4 had FC27 alleles of the msp2 gene. No 
mutated S1105 and S1240 alleles and 6 mutant VDT alleles were found in P. vivax. It can be concluded 
that the resistance of parasites to SP was quite high, indicating the highly urgency to develop malaria 
vaccine. 
Keywords : resistance, dhfr, dhps, mutation, malaria vaccine 
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INTRODUCTION 
Malaria is one of the diseases with a high 
prevalence rate in the world. Approximately 3.3 
billion people in 97 countries and territories are at 
risk of being infected with malaria. According to 
the World Health Organization (WHO), morbidity 
and mortality due to malaria tend to decline in the 
period 2005-2015. In 2015, an estimated 214 
million new cases of malaria occurred with the 
death of around 438 thousand people worldwide 
[1]. Indonesia with a population of around 265 
million is one country that has a high mortality 
rate in malaria cases. This country is also a place 
for more than 20 Anopheles vectors of malaria 
which transmit the four species of Plasmodium sp. 
which infects humans [2]. By implementing all 
efforts Indonesia marked a milestone in 2017 with 
more than half of districts officially declared 
malaria free. 
Malaria is a disease that originates from 
Plasmodium sp. infection and including deadly 
diseases both in animals and humans [1], [3]. P. 
falciparum and P.vivax are parasites that cause the 
greatest health problems in Indonesia, where most 
of the deaths are caused by these two parasites. A 
total of 56% of P. falciparum parasites and 44% 
of P. vivax parasites were recorded as the two 
species that infected malaria in Indonesia in 2013 
[4]. The highest prevalence of malaria caused by 
P. falciparum parasites is found in the eastern part 
of Indonesia, especially in the Papua region [2].  
SP or Fansidar antimalarial drugs are used 
as a second-line treatment by inhibiting the action 
of the dihydrofolate reductase (dhfr) and 
dihydropteroate synthase (dhps) genes in folate 
biosynthetic pathways, and are believed to 
increase antimalarial potential and reduce the risk 
of drug resistance. However, resistance to this 
drug combination was reported to occur shortly 
after the introduction of the drug. The spread of 
resistance to SP drugs has become a public health 
problem because the drug is still used as an 
alternative to malaria treatment [5]. Beside that 
genetic diversity of the gene coding for merozoite 
surface protein 2 (msp2) of P. falciparum that is 
abundant surface protein on the blood stage of 
parasite can be used in understanding malaria 
control and elimination programs. The locus of 
this gene is extremely polymorphic with two 
allelic families (3D7 and FC27), both of which are 
closely associated with clinical manifestation, 
severity of malaria and demographic factors [6], 
[7].  
Plasmodium sp. parasite resistance against 
antimalarial drugs can be caused by many factors. 
Molecular studies that carried out by detecting the 
mutations of dhfr and dhps genes are believed to 
have an effect on antimalarial drug resistance [8]. 
Further molecular studies need to be done by 
looking at the polymorphism to determine the 
effect of genes on antimalarial drug resistance. 
Genetic variation in P. falciparum is reported to 
be quite high and results in new parasites. This 
gene variability can also be used to see the 
frequency of recurrent infections in humans [9]. 
Dihydrofolate reductase (dhfr) is a gene that 
influences folic acid biosynthesis [10] and is 
targeted by pyrimethamine drugs in malaria 
parasites. Mutations in this gene are related to 
resistance to pyrimethamine drugs [11]. 
Resistance to other antimalarial drugs of 
sulfadoxine is related to mutations in the dhps 
gene. Detection of mutations in both genes is 
widely done to see the correlation between 
mutations with drug resistance. On the other hand, 
the pvdhfr and pvdhps genotypes might also be 
associated with treatment failure in individual 
vivax malaria-infected patients [12]. 
Analysis of genetic variation that has 
accurate results has a lot of influence on 
biomedical research. Analysis with method such 
as an RFLP is widely used to detect the presence 
of single nucleotide polymorphisms (SNP) [13]. 
One other alternative to detect mutation is single-
strand conformation polymorphism (SSCP) with 
high accuracy and sensitivity [14]. More recently 
it is also described protocols that utilize silver 
staining or with fluorescent dyes [15]. 
The existing frontline malaria control 
interventions such as vector control by indoor 
residual spraying are expensive and even not 
effective due to the emergence of drug resistance 
[16]. It calls for an innovative approach in terms 
of potential and reliable vaccine as an additional 
tool and could be primed for breakout. Ionizing 
radiation has become a reliable tool to create a 
cost-effective vaccine for this deadly disease, 
where early our study found that 150 Gy of 
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gamma rays was effectively to attenuate parasites 
as vaccine material [17], [18].  
 This study aims to detect mutations in the 
genes encoding antimalarial drug resistance and 
genetic variation in Plasmodium, namely the dhfr 
and dhps genes in P. falciparum and P. vivax 
parasites as well as msp-2 with PCR-RFLP as a 
basic information for the development of malaria 
vaccine in Indonesia to achieve effective disease 
control.
 
 
MATERIALS and METHODS 
Object of Research  
 The object of this study was DNA sample of 
P. falciparum and P. vivax parasites which had 
been extracted from blood samples dropped on a 
filter paper of malaria infected patients (with no 
previous information on its drug resistance) 
attending the Dok II Hospital, Jayapura City, 
Papua Province. The blood sampling was done in 
September 2014. Monitoring of parasite infection 
in the blood samples was performed using 
microscopic evaluation of thick blood smear that 
was first fixed with methanol (Merck), and then 
stained with Giemsa (Sigma). Fifteen samples 
obtained from 9 males and 6 females (due to 
limited time of sampling) that were stored 
individually in zip-lock bags were tested for dhfr 
and dhps polymorphisms. 
 
Ethical of the Research  
 Research procedures and obtaining blood 
samples of suspected of malaria patients have 
been approved by the Ethics Commission, 
National Institute of Health Research and 
Development, Ministry of Health in Jakarta (No. 
LB.02.01/5.2/KE.162/2014 dated of 24 April 
2014, and permitted from Jayapura General 
Hospital, Papua, Indonesia. Informed consent was 
given to all respondents or patients being infected 
with malaria who participated in this research. 
 
Microscopic observation 
 Malaria species infecting the blood samples 
was determined by the thick smears. A drop of 
blood obtained from patient was put on the clean 
glass slide, air dried and then was stained with 
Giemsa following standard procedures. 
 
DNA extraction  
 The DNA of P. falciparum parasite was 
extracted from blood sample using Chelex-100 ion 
exchanger (Biorad Laboratories, Hercules, CA, 
USA) and followed the standard procedures as 
described by Asih dkk. [19]. The filter paper with 
dropped blood was placed in a microtube, 100 µl 
distilled water and 50 µl 20% Chelex-100 in 
distilled water were added. DNA was extracted by 
boiling it at 100 °C for 10 min. DNA samples 
were then be used immediately for PCR 
amplification or stored in a freezer at -20°C for 
later analysis. 
 
Amplification of DNA with nested PCR  
 PCR amplification for genotyping of SP drug 
resistance encoding dhfr and dhps genes was 
carried out using the nested PCR principle. PCR 
was carried out at 25 μL reaction volume 
containing 1x Buffer, 1.57 mM MgCl2 
(Invitrogen), 120 μM of dNTP, 0.4 units of Taq 
DNA polymerase, 30 μM of each oligonucleotide 
primer and 5 μL of DNA template. The nested 
PCR method is used to amplify the resistance 
encoding genes because this method can increase 
the sensitivity of gene mutation detection. In 
nested PCR, the amplification reaction was 
performed twice. In the first reaction, the 
oligonucleotide primer sandwiches the 
polymorphic region of the gene used. In the 
second reaction, the first product PCR reaction of 
2 μL was used as a DNA template (amplicon) 
(Figure 1). The primary nucleotide sequences used 
in nested-PCR are shown in Table 1 where the 
pair of primers is as follow: JR84-JR85, L-L’, 
JR78-JR79, F-108DH for P. falciparum, VDT of - 
VDT ON and VDT-OF – VDT-OR for P. vivax, 
and S2-S3 and S1-S4 for msp-2 genotyping. The 
PCR conditions were performed according to 
Abdullah dkk. [20] and Imwong dkk. [21]. Briefly, 
the PCR (Applied Biosystems, USA) involved 30 
amplification cycles composed of initial 
denaturation at 94°C for 5 minutes, a denaturing 
step at 94°C for 1 minute, followed by annealing 
at 55°C for 2 minutes, and an extension step for 2 
minutes at 72°C. 
 For msp-2 genotyping, in the initial 
amplification, primer pairs corresponding to 
conserved sequences within the polymorphic 
regions of gene were included in separate 
reactions. The product of initial amplification was 
used as a template in two separate nested PCR. In 
the nested reaction, separate primer pairs targeted 
the respective allelic types of msp-2 (3D7 and 
FC27) with an amplification mixture containing 
250 nM of each primer, 2 mM of MgCl2 and 
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125 µM of each dNTPs and 0.4 units Taq DNA 
polymerase. The cyclic conditions in the 
thermocycler for initial reaction were: 5 min at 
95°C, followed by 30 cycles for 1 min at 94°C, 
2 min at 58°C and 2 min at 72°C and final 
extension of 10 min at 72°C. For nested PCR, 
conditions were: 5 min at 95°C, followed by 30 
cycles for 1 min at 95°C, 2 min at 61°C and 2 min 
at 72°C and final extension of 5 min at 72°C. 
 
 
 
Figure 1. Schematic of nested PCR reactions. The 
arrow indicates the forward primer (1F) and 
reverse primer (1R) for the first round and the 
product 1 is then used as template for second 
round [22]. 
 
Detection of mutation with RFLP 
The nested PCR products were then 
detected their mutation with restriction digestion. 
For dhfr and dhps of P. falciparum, the PCR 
products were digested with NlaIII and TaiI (dhfr) 
and Msp A1I, Ava II (dhps) enzymes to determine 
the polymorphisms at codons of 15 and 60 (dhfr) 
and 436 and 437 (dhps) as described by 
Syafruddin dkk. [8] and Asih dkk. [19]. For dhps 
of P. vivax, the PCR products were digested with 
Msp1 and Msc1 enzymes as described by Asih 
dkk. [19] and Imwong dkk. [21] for the analysis of 
VDT allele. Digested products were subjected to 
electrophoresis on 1.5−3% agarose gels (Progen, 
Australia), stained with ethidium bromide, then 
observed under UV light, and photographed. A 
100 pb ladder was used as a DNA size was used as 
a marker on all gels [19]. For msp-2, enzyme of 
Hinf I was used and members of the 3D7-type 
alleles produced two conserved restriction 
fragments (70 and 108 base pairs (bp)), whereas 
FC27-type alleles produced two conserved 
fragments (115 and 137 bp). 
 
RESULTS and DISCUSSION  
Detection of species 
Based on microscopic observation it was 
known that from 15 samples analyzed, 9 samples 
were infected with P. falciparum (Figure 2) which 
characterized by the presence of young 
trophozoite and sausage-shaped gametocyte. Six 
were infected with P. vivax (Figure 2) which
 
Table 1. Sequence of nucleotide alleles / primers used in nested PCR for dhfr, dhps and msp-2 genes 
either for the first round or second round of PCR [8], [19], [20], [21] 
 
No. 
Allele/ 
primer Nucleotide array References 
dhfr – dhps  
P.falciparum 
  
1. JR84 5’-GGT ATT TTT GTT GAA CCT AAA CG-3’ 19-21 
2. JR85 5’-ATC CAA TTG TGT GAT TTG TCC AC-3’  
3. L 5’-ATA GGA TAC TAT TTG ATA TTG GAC CAG GAT TCG-3’ 19-21 
4. L’ 5’-TAT TAC AAC ATT TTG ATC ATT CGC GCA ACC GG-3’  
5. JR78 5’-CTC CTT TTT ATG ATG GAA CAA GTC-3’ 19-21 
6. JR79 5’-CAT CAC ATT CAT ATG TAC TAT TTA TTC TAG T-3’  
7. F 5’-GAA ATG TAA TTC CCT AGA TAT GGA ATA TT-3’ 19-21 
8. 108DH 5’-GGT TCT AGA CAA TAT AAC ATT TAT CC-3’  
P. vivax   
9. VDT OF 5′-ATG GAG GAC CTT TCA GAT GTA TTT GAC ATT-3′ 21 
10. VDT ON 5′-GGC GGC CAT CTC CAT GGT TAT TTT ATC GTG-3′  
11. VDT OR 5′-CTT GCT GTA AAC CAA AAA GTC CA-3′  
Msp-2   
12. S2 5’-GAA GGT AAT TAA AAC ATT GTC-3’ 8 
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13. S3 5’-GAG GGA TGT TGC TGC TCC ACA-3’  
14. S1 5’-GAG TAT AAG GAG AAG TAT G-3’  
15. S4 5’-CTA GAA CCA TGC ATA TGT CC-3’  
characterized by the presence of trophozoite and 
schizont and Schüffner stippling. Two samples 
were infected by both P. falciparum and P. vivax. 
Two samples were not infected either by P. 
falciparum or P. vivax. 
 
 
 
 
Figure 2. Microscopic observation of Giemsa stained 
thick smear of P. falciparum species (upper) 
of patient no. 1 and P. vivax species (below) 
of patient no. 4 infecting the blood samples 
with its own characteristics explained in text 
and the magnification of 1000X 
 
 
 
 
 
 
 
 
 
 
 
 
 
Detection of mutated dhfr and dhps genes 
DNA amplification with nested PCR is a 
very sensitive method for the detection of specific 
parasite species as its capable of identifying as 
few as 1-10 parasites/μL (low parasitemia) which 
may missed by microscopy observation, including 
mixed infections. In this study nested PCR 
amplification of DNA samples from P. falciparum 
infected patients followed by RFLP technique was 
done to detect mutations. The screening of the 
prevalence of these mutations could facilitate the 
surveillance of the level of S/P resistance in vivo. 
PCR amplification of two genes encoding anti-
malaria drug resistance (dhfr and dhps genes) was 
carried out in 15 samples. The results showed that 
by using JR78/79 primer from dhfr gene, there 
were 9 samples which showed positive RFLP 
results, whereas with F/108DH primers there were 
8 samples which showed positive RFLP results. 
The results of PCR amplification on dhps genes 
using JR84/85 primer and L/L primer showed that 
7 samples were positive from 15 samples tested. 
For P. vivax polymorphism test there is no 
mutated S1105 and S1240 alleles and 6 mutant 
VDT alleles were found. All these results are 
presented in Table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The PCR results for msp-2 genotyping of P. falciparum with the appearances of 3D7 (upper) and FC27 
(lower) alleles. M: marker of 100 bp, N: negative control 
M  1   2   3   4   5   6   7  8  9  10  11 1213 14 15 N  
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Table 2.  The results of RFLP analysis of dhfr, dhps and msp-2 genes of P. falciparum and P. vivax parasites from 
blood samples of malaria infected Papua outpatients 
 
No. 
Sample 
Pfdhfr  Pfdhps  Msp-2  Pvdhfr  Pvdhps 
JR78/JR79 F/108DH  JR84/JR85 L/L"  3D7 FC27  S1105 S1240  VDT 
1 + +  + +  - +  - -  - 
2 + +  + +  + +  - -  - 
3 + +  + +  - +  - -  - 
4 - -  - -  - -  - -  + 
5 - -  - -  - -  - -  + 
6 + -  - -  - -  - -  + 
7 + +  + +  - -  - -  + 
8 + +  + +  + -  - -  - 
9 - -  - -  - -  - -  + 
10 - -  - -  - -  - -  + 
11 - -  - -  - -  - -  - 
12 - -  - -  - -  - -  - 
13 + +  + +  + -  - -  - 
14 + +  + +  - +  - -  - 
15 + +  - -  - -  - -  - 
 
Genotyping of msp2 
Of totally 15 samples tested for the msp2 
gene, 3 (20%) PCR-positive samples had 3D7 
alleles and 4 (26.7%) had FC27 alleles (Table 2). 
In this research FC27 alleles were higher 
compared to 3D7. There is no information on the 
polyclonal or monoclonal infected P. falciparum 
isolates. The positive results of the msp2 gene are 
marked by the appearance of the band on the PCR 
amplification results (Figure 3). Even though there 
is no direct relationship between msp-2 and SP 
resistance, msp-2 genotyping is very important as 
it can be used to differentiate recrudescence, as 
well as marker to investigate the genetic diversity, 
multiplicity of infection, the level of malaria 
transmission, and immunity against malaria [23], 
[24], [25].  
Various drug resistance analysis has been 
done mainly in east part of Indonesia as the most 
malarious provinces [8],[19],[26]. Here a very 
limited number of samples from Papua were 
analyzed their resistance to SP based on dhps and 
dhfr gene mutations. In this study the number of 
samples that undergo polymorphism-based 
mutations is quite high. But these results are still 
lower than the results of other studies that found 
Pfdhfr mutations up to 100% each in Tanzania 
[27], in the Amazon [28], in Iran [29] and in East 
Timor [30]. At different locations de Almeida [30] 
found mutations of up to 97% (62 of 64). A high 
percentage of mutation was also found at 95% in 
Mozambique [31], and was quite high at 57% 
(12/21) in Burkina Faso [32]. For Indonesia areas 
(Alor and Lampung) these resistances were 71.2% 
and 87.2%, respectively [33]. This difference is 
due to differences in detection methods used, 
alleles or polymorphisms tested and other factors. 
Output epidemiological studies state that malaria 
infection will differ between ecotypes or ecology 
and the world's climate, even between small 
ecological sectors, so malaria is a local or focal 
disease [34].  
In malaria endemic regions such as in 
Papua, P. falciparum infection is characterized by 
extensive genetic diversity which is important 
information about the local malaria situation. Here 
in this research msp-2 gene that is associated with 
an immune response was analyzed its 
polymorphisms. The genetic diversity of 
P. falciparum has been extensively studied in 
many parts of the world [6], [7], [9], [19], [20], 
[27], [28], [29], [30], but quite limited data are 
available from Indonesia especially in Papua. 
Therefore, this study was conducted to 
understanding that the genetic diversity of malaria 
parasites in residual transmission foci can provide 
invaluable additional information in the 
intervention strategies used to reach elimination 
targets such as malaria vaccine treatment. 
The research implications are that there is 
need to conduct further high powered study to 
explore alternative avenues such as vaccine if it is 
to be beneficial. Beside that this genotyping in SP 
drug resistance, even though this drug is not used 
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for P. vivax treatment in Indonesia [26], is 
important in order to improve the national 
antimalarial drug policy. Although the existing 
conventional vector control interventions are 
competent to minimize the malaria burden 
considerably, they remain unproductive to 
eradicate malaria. In this context, introduction of 
malaria vaccine could be one of the most 
sustainable and cost-effective approach in the 
malaria prevention and control strategy [16]. 
Preliminary study revealed that the successful use 
of irradiated plasmodium as a vaccine materials 
depends on finding the radiation dose and dose 
rate which significantly reduces the pathogenic 
effect of the microorganism without seriously 
impairing their immunogenic power [18].  
PCR-based mutation detection techniques 
such as RFLP are an alternative technique that are 
useful for studying genetic variation in a 
population [13], [35]. This enzymatic chain 
reaction is a molecular biology technique that 
enables the enzymatic synthesis process to 
amplify DNA fragments [36]. PCR techniques are 
now commonly used especially in the fields of 
molecular biology and biomedicine. PCR is the 
most widely used technique in molecular biology 
because the process is fast and simple [37]. 
 
CONCLUSION 
Of the 15 samples tested for P. falciparum, 
it was found that for dhfr and dhps genes, there 
were 9 and 8 positive samples mutated in both 
alleles based on RFLP, respectively. For P. vivax, 
it was found that for dhfr and dhps genes, there 
were 0 and 6 positive samples mutated in both 
alleles based on RFLP. It was concluded that 
mutations causing parasitic resistance to SP were 
quite high as was evident in this study that 
alarming the need for developing vaccine.
 
 
ACKNOWLEDGEMENTS 
The authors would like to give sincere 
thanks to Marantina SS from Malaria Group, 
Eijkman Institute for Molecular Biology in Jakarta 
for their technical assistance. This study received 
financial assistance from Annual Research Project 
of the Center.  
 
REFERENCES 
[1] World Health Organization, "World Malaria 
Report", Geneva: Switzerland, 2016. 
[2] I.R.F. Elyazar, S.I. Hay, K.J. Baird, "Malaria 
Distribution, Prevalence, Drug Resistance 
and Control in Indonesia," J Adv Parasitol., 
Vol. 74, pp. 41-175, 2011. 
 
[3] C.I. Sandefur, J.M. Wooden, I.K. Quaye, 
dkk., "Pyrimethamine-Resistant 
Dihydrofolate Reductase Enzymes of P. 
Falciparum are not Enzymatically 
Compromised In Vitro," Mol Biochem 
Parasitol. Vol. 154, No. 1, pp. 1-5, 2007. 
 
[4] World Health Organization. World Malaria 
Report. Geneva. Switzerland; 2014. 
 
[5] R.A. Ghani, H.F. Farag, A.F. Allam, 
"Sulfadoxine-Pyrimethamine Resistance In 
Plasmodium Falciparum: A Zoomed Image 
at The Molecular Level Within A Geographic 
Context," J Act Tropica, Vol. 125, pp. 163-
190, 2013. 
 
[6] I. Felger, L. Tavul, S. Kabintik, dkk. 
"Plasmodium falciparum: Extensive 
Polymorphism In Merozoite Surface Antigen 
2 Alleles In An Area with Endemic Malaria 
In Papua New Guinea," Experimental 
Parasitology, Vol. 79, No. 2, pp. 106–116, 
1994. 
 
[7] W.M. Atroosh, H.M. Al-Mekhlafi, M.A 
Mahdy, dkk., "Genetic Diversity of 
Plasmodium falciparum Isolates from 
Pahang, Malaysia based on msp-1 and msp-
2 Genes," Parasit Vectors., Vol. 4, pp. 233, 
2011. 
 
[8] D. Syafruddin, P.B.S. Asih, G.J. Casey, dkk. 
"Molecular Epidemiology of Plasmodium 
falciparum Resistance to Antimalarial Drugs 
in Indonesia," J Am Trop Med Hyg. Vol. 72, 
pp. 174-181, 2005. 
 
[9] R. Peek, T. V. Gool, D. Panchoe, dkk. Greve 
S, Bus E, Resida L. Drug Resistance and 
Genetic Diversity of Plasmodium falciparum 
Parasites from Suriname. Am J Trop Med 
Hyg., Vol. 73, No. 5, pp. 833-838, 2005. 
 
[10] A. Nzila, "Inhibitors of de novo folate 
Enzymes in Plasmodium falciparum," Drug 
Discov Today. Vol. 11, pp. 939-944, 2006. 
 
  136 
Jurnal Ilmiah Aplikasi Isotop dan Radiasi 
A Scientific Journal for The Applications of Isotopes and Radiation 
Vol. 15 No.2 Desember 2019 
 
p ISSN 1907-0322 
e ISSN 2527-6433 
 
[11] C. Roper, R. Pearce, S. Nair, dkk., 
"Intercontinental Spread of Pyrimethamine-
Resistant Malaria," Science, Vol. 305, 
p.1124, 2004. 
 
[12] S. Kaura, S.K. Prajapatib, K. Kalyanaramana, 
dkk., "Plasmodium vivax Dihydrofolate 
Reductase Point Mutations from The Indian 
Subcontinent," Acta Trop., Vol. 97, pp.74–
180, 2006. 
 
[13] R.B. Gasser, M. Hu, N.B. Chilton, dkk. 
"Single-Strand Conformation Polymorphism 
(SSCP) for The Analysis of Genetic 
Variation," Nature, Vol. 1, No. 6, pp. 3121-
3128, 2007. 
 
[14] M. Syaifudin, S. Purnami, D. Tetriana, 
"Detection of pNCA Gene Mutations as A 
Cause of Resistance to M. tuberculosis 
Against Pyrazinamide by PCR-SSCP and 
Autoradiography Techniques," Proceeding 
PPI - PDIPTN, Yogyakarta, pp. 20-27, 2010. 
 
[15] P. G. Menounos, G.P. Patrinos, "Mutation 
Detection by Single Strand Conformation 
Polymorphism and Heteroduplex Analysis," 
Molecular Diagnostic. pp. 45-58, 2010. 
 
[16] K. Karunamoorthi, "Malaria Vaccine: A 
Future Hope to Curtail The Global Malaria 
Burden," Int J Prev Med., Vol. 5, No. 5, 
pp.529–538, 2014. 
 
[17] M. Syaifudin, D. Tetriana, Darlina, dkk., 
"The Feasibility of Ionizing Radiation as A 
Tool for Developing Malaria Vaccine," Atom 
Indonesia, Vol. 37, No. 3, pp. 91-101, 2011. 
 
[18] M. Syaifudin, Darlina, T. Rahardjo, dkk., 
"Efectiveness of Gamma Rays in Attenuating 
Rodent Malaria Parasites of Plasmodium 
Berghei in Blood of Mice," Atom Indonesia, 
Vol. 39, No. 1, pp. 19-23, 2013. 
 
[19] P.B.S. Asih, S.S. Marantina, R. Nababan 
dkk., "Distribution of Plasmodium Vivax 
Pvdhfr and Pvdhps Alleles and Their 
Association With Sulfadoxine-
Pyrimethamine Treatment Outcomes In 
Indonesia," Malar J., Vol. 22, No.14, pp. 
365, 2015. 
 
[20] N.R. Abdullah, N.A. Norahmad, J. Jelip, 
dkk., "High Prevalence of Mutation In The 
Plasmodium Falciparum Dhfr and Dhps 
Genes In Field Isolates from Sabah, Northern 
Borneo," Malar J., Vol.12, pp. 198, 2013. 
 
[21] M. Imwong, S. Pukrittayakamee, Q. Cheng, 
dkk., "Limited Polymorphism In The 
Dihydropteroate Synthetase Gene (dhps) of 
Plasmodium vivax isolates from Thailand," 
Antimicrob Agents Chemother., Vol. 49, pp. 
4393-4395, 2005. 
 
[22] Anonymous, PCR primer design and reaction 
optimization (cited 2016 Sept 16). Available 
from: http://refer.biovip.com/doc-view-
8022.html. 
 
[23] R. Fatria, "Detection of Polymorphisms In 
Genes Encoding Resistance of Plasmodium 
falciparum (DHPS, DHFR and MSP-2) to 
Antimalarial Drugs With The SSCP 
Method,". Jakarta: Al-Azhar University; 
2016. 
 
[24] K. Congpuong, R. Sukaram, Y. Prompan 
dkk., "Genetic Diversity of The Msp-1, Msp-
2, and Glurp Genes of Plasmodium 
Falciparum Isolates Along The Thai-
Myanmar Borders," Asian Pac J Trop 
Biomed., Vol. 4(8), pp. 598–602, 2014. 
 
[25] P. Rouse, M.A.P.Mkulama, P.E. Thuma dkk., 
"Distinction of Plasmodium Falciparum 
Recrudescence and Re-Infection By MSP2 
Genotyping: A Caution About 
Unstandardized Classification Criteria," 
Malar J., Vol. 7, pp. 185, 2008.  
 
[26] P.B.S. Asih, R.M. Dewi, S. Tuti, dkk., 
"Efficacy of Artemisinin-Based Combination 
Therapy For Treatment of Persons With 
Uncomplicated Plasmodium Falciparum  
Malaria In West Sumba District, East Nusa 
Tenggara Province, Indonesia, and Genotypic 
Profiles of The Parasite." Am. J. Trop. Med. 
Hyg., Vol. 80, pp. 914–918, 2009. 
 
[27] T. Jelinek, A.M. Ronn, J. Curtis, dkk., "High 
Prevalence of Mutations In The 
Dihydrofolate Reductase Gene of 
Plasmodium Falciparum In Isolates From 
Tanzania Without Association to Clinical 
  137 
Deteksi Resistensi Parasit terhadap Obat Sulfadoksin-Pirimetamin dan 
Genotyping msp-2 sebagai Dasar Pengembangan Vaksin Malaria dengan 
Radiasi Pengion 
(Syaifudin, dkk) 
 
p ISSN 1907-0322 
e ISSN 2527-6433 
 
Resistance to Sulfadoxine/ Pyrimethamine," 
Tropical Medicine and International Health, 
Vol. 2, No.11, pp. 1075-1079, 1997. 
[28] J.G. Kublin, R.S. Witzig, A.H. Shankar, dkk.,  
"Molecular Assays For Surveillance of 
Antifolate-Resistant Malaria," Lancet, Vol. 
98, No. 351, pp.1629-1630, 1998. 
 
[29] S. Zakeri, M. Afsharpad, A. Raeisi, dkk., 
"Prevalence of Mutations Associated With 
Antimalarial Drugs In Plasmodium 
Falciparum Isolates Prior to The Introduction 
of Sulphadoxine-Pyrimethamine As First-
Line Treatment In Iran," Malar J., Vol. 6, 
pp.148, 2007. 
 
[30] A.D. Almeida, A.A.P. Arez, P.V.L. Cravo, 
dkk., "Analysis of Genetic Mutations 
Associated With Anti-Malarial Drug 
Resistance in Plasmodium falciparum from 
the Democratic Republic of East Timor," 
Malar J., Vol. 8, pp. 59, 2009. 
 
[31] N. Fernandes,  P. Figueiredo, V.E.D. Rosario, 
dkk., "Analysis of Sulphadoxine/ 
Pyrimethamine Resistance-Conferring 
Mutations of Plasmodium falciparum from 
Mozambique Reveals The Absence of The 
Dihydrofolate Reductase 164L Mutant," 
Malar J., Vol. 6, pp. 35, 2007. 
 
[32] H. Tinto, J.B. Ouedraogo, I. Zongo, dkk., 
"Sulfadoxine-pyrimethamine efficacy and 
Selection of Plasmodium falciparum DHFR 
Mutations in Burkina Faso before its 
Introduction as Intermittent Preventive 
Treatment For Pregnant Women," Am J Trop 
Med Hyg., Vol. 76, pp. 608-613, 2007. 
[33] A.I. Susanti, "Mutation of Dihydrofolate 
Reductase (DHFR) and Dihydropteroate 
Synthase (DHPS) Genes of Plasmodium 
Falciparum from Two Areas With Different 
Efficacy of Sulfadoxine/Pirimethamine," 
Universitas Indonesia Research Report from 
JKPKBPPK, 2005. 
 
[34] J.E. Conn, D.E. Norris, M.J. Donnelly, dkk., 
"Entomological Monitoring and Evaluation: 
Diverse Transmission Settings of ICEMR 
Projects Will Require Local and Regional 
Malaria Elimination Strategies," Am. J. Trop. 
Med. Hyg., Vol. 93, pp.28-41, 2015. 
 
[35] M. Syaifudin, D. Tetriana, B. Bela, 
"Implementation of Nuclear Techniques For 
The Analysis of Mycobacterium Tuberculosis 
Resistance to Rifampicin," Proceeding PPI – 
PDIPTN, Yogyakarta. pp. 27-34, 2006. 
 
[36] D. Handoyo, A. Rudiretna, "General 
Principles and Implementation of Polymerase 
Chain Reaction," Unitas., Vol. 9, No. 1, pp. 
17-29, 2000. 
 
[37] M. Joshi, D. Deshpande, "Polymerase Chain 
Reaction: Methods, Principles and 
Application," Int J Bio Res., Vol. 5, pp. 81-
97, 2010.  
  138 
Jurnal Ilmiah Aplikasi Isotop dan Radiasi 
A Scientific Journal for The Applications of Isotopes and Radiation 
Vol. 15 No.2 Desember 2019 
 
p ISSN 1907-0322 
e ISSN 2527-6433 
 
 
